The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mezigdomide, carfilzomib, and dexamethasone (MeziKd) vs carfilzomib and dexamethasone (Kd) in relapsed/refractory multiple myeloma (RRMM): Results from the phase 3 SUCCESSOR-2 trial.
 
Paul Richardson
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Karyopharm Therapeutics; Oncopeptides; Regeneron; Sanofi
Research Funding - Oncopeptides
 
Fredrik Schjesvold
Honoraria - Abbvie; Amgen; BMSi; GlaxoSmithKline; Johnson & Johnson/Janssen; Menarini; Oncopeptides; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - BMSi; Caedo therapeutics; Galapagos NV; GlaxoSmithKline; Johnson & Johnson/Janssen; Oncopeptides; Pfizer; Regeneron; Sanofi; Takeda; XNK therapeutics
Research Funding - Circio
Expert Testimony - GlaxoSmithKline
 
Chengcheng Fu
No Relationships to Disclose
 
Monique Hartley-Brown
Employment - Bristol-Myers Squibb/Celgene; GlaxoSmithKline
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Sanofi
 
Cesar Gomez
No Relationships to Disclose
 
Donna Reece
Honoraria - Bristol-Myers Squibb; Janssen; Pfizer; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Research Funding - Bristol Myers Squibb Foundation (Inst); Janssen (Inst); ORIC Pharmaceuticals (Inst); Sanofi (Inst)
Expert Testimony - Janssen
 
Gabor Mikala
No Relationships to Disclose
 
Omar Alkharabsheh
Honoraria - Curio Science
Consulting or Advisory Role - Agios; Amgen; AstraZeneca; AstraZeneca; BMSi; Daiichi Sankyo; Genentech; Incyte; NCODA
Research Funding - Celgene/Bristol-Myers Squibb (Inst); Loxo/Lilly (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - BMSi
 
Christopher Parrish
Consulting or Advisory Role - Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Janssen; Pfizer; Sanofi
 
Darrell White
Honoraria - Amgen; Antengene; Apobiologix; Bristol-Myers Squibb; Forus; GlaxoSmithKline; Karyopharm Therapeutics; Pfizer; Sanofi
 
Hang Quach
Consulting or Advisory Role - Antengene (Inst); Bristol-Myers Squibb/Celgene; GlaxoSmithKline (Inst); Janssen-Cilag; Karyopharm Therapeutics (Inst); Pfizer; Roche; Sanofi (Inst)
Research Funding - Amgen; Bristol-Myers Squibb/Celgene; Celgene; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi
 
Claudio Cerchione
Honoraria - Abbvie; Amgen; BeiGene; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Menarini; Pfizer; Sanofi/Aventis; SERVIER; Stemline Therapeutics; Takeda
Consulting or Advisory Role - Abbvie; Amgen; BeiGene; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Menarini; Pfizer; Sanofi; SERVIER; Stemline Therapeutics; Takeda
Speakers' Bureau - Abbvie; Amgen; BeiGene; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Menarini; Pfizer; Sanofi/Aventis; SERVIER; Stemline Therapeutics; Takeda
 
Vania Hungria
Consulting or Advisory Role - Abbvie; Amgen; BMS Brazil; GlaxoSmithKline; Johnson&Johnson; Pfizer; Regeneron; Roche; Sanofi; Takeda
Speakers' Bureau - Abbvie; Amgen; BMS Brazil; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi; Takeda
 
Amitabha Mazumder
No Relationships to Disclose
 
Marc Raab
Honoraria - Abbvie; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Pfizer (Inst); Sanofi (Inst)
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Janssen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Sanofi
 
Albert Oriol Rocafiguera
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Sanofi
 
Zehua Zhou
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Alberto Rocci
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Brian Yu
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Meletios Dimopoulos
Honoraria - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb/Celgene; Janssen; Takeda